I was a bit eager to criticize. Whilst Clinuvel very clearly didn’t get fda “approval” in 2016. They did get “designation” for vp as an orphan disease. Poor language, but not as bad as first thought. Apologies.
- Forums
- ASX - By Stock
- CUV
- Ann: SCENESSE European Orphan Drug Designation for VP
Ann: SCENESSE European Orphan Drug Designation for VP, page-8
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$14.72 |
Change
-0.100(0.67%) |
Mkt cap ! $737.1M |
Open | High | Low | Value | Volume |
$14.80 | $14.97 | $14.60 | $600.3K | 40.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 324 | $14.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.75 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20 | 14.600 |
1 | 400 | 14.560 |
1 | 100 | 14.530 |
1 | 1652 | 14.520 |
3 | 1227 | 14.510 |
Price($) | Vol. | No. |
---|---|---|
15.050 | 1000 | 1 |
15.080 | 348 | 1 |
15.600 | 350 | 1 |
15.800 | 341 | 1 |
15.990 | 1100 | 2 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |